HDAC inhibitors also elicited potent antitumor effects on AML at multiple levels, including cell cycle arrest induction, apoptosis, differentiation, inhibition of angiogenesis, and cell migration and invasion [26,27,28,29]. The gene discussed is HDAC9; the disease is acute myeloid leukemia.